Breaking News, Collaborations & Alliances

AstraZeneca, CSPC Pharmaceuticals Partner for Novel Oral Therapies

The collaboration aims to advance the discovery and development of novel oral candidates.

Author Image

By: Charlie Sternberg

Associate Editor

AstraZeneca has entered a strategic research collaboration with China’s CSPC Pharmaceuticals Group Limited, focusing on the discovery and development of novel oral drug candidates for various chronic diseases. The partnership aims to leverage both companies’ scientific expertise to advance preclinical molecules, including a small molecule oral therapy for immunological diseases. CSPC Pharmaceuticals, based in Shijiazhuang City, will lead the research efforts, utilizing its AI-driv...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters